|
|
||||||||
European Journal of Cardio-Thoracic Surgery, Vol 10, 38-47, Copyright © 1996 by European Association for Cardio-thoracic Surgery
MJ Unsworth-White, P Kallis, D Cowan, JA Tooze, DH Bevan and T Treasure
Autotransfusion has been included in the routine protocol in some units as
an effort towards blood conservation. In this study we aimed to measure the
efficacy and limitations of autotransfusion and whether a heparin-bonded
circuit had any advantage. One hundred five patients were randomised to one
of three post-operative treatments. Group 1 (n = 34) was not autotransfused
whereas groups 2 (n = 36) and 3 (n = 35) received autotransfusion with the
circuit of group 3 coated with heparin. Homologous blood and blood products
were given according to strict protocols identical for all groups.
Transfused and circulating blood was analysed for haemostatic variables and
the requirement for homologous blood was recorded. Autotransfused blood
contained no intact platelets and very high levels of D-Dimers (a peptide
fragment released when fibrin is lysed) which resulted in high levels of
systemic D- Dimers in patients receiving autotransfusion. Flow cytometric
analysis revealed that whilst platelet glycoprotein 1 b receptors were
severely reduced immediately following surgery, there was no additional
damage caused by autotransfusion. Furthermore, there was no difference in
platelet aggregation, von Willebrand factor (vWF) multimetric analysis or
clotting profiles between the groups. Median (interquartile range) blood
loss was 898 ml (638-1195) in group 1, 853 ml (595-1348) in group 2 and 770
ml (615-1000) in group 3 (Kruskal-Wallis P = 0.46). Median transfusion
requirements were 2 units in each group. Whilst auto- transfusion does not
appear to compromise haemostasis, it does not reduce the requirement for
homologous blood and heparin-bonding of the circuit has no impact.
ARTICLES
A prospective randomised controlled trial of postoperative autotransfusion with and without a heparin-bonded circuit
Department of Cardiothoracic Surgery, St. George's Hospital, London, UK.
This article has been cited by other articles:
![]() |
O. Mangoush, S. Purkayastha, S. Haj-Yahia, J. Kinross, M. Hayward, F. Bartolozzi, A. Darzi, and T. Athanasiou Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1058 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Johnell, G. Elgue, R. Larsson, A. Larsson, S. Thelin, and A. Siegbahn Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface J. Thorac. Cardiovasc. Surg., August 1, 2002; 124(2): 321 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Huet, L. R. Salmi, D. Fergusson, A. W. M. M. Koopman-van Gemert, F. Rubens, and A. Laupacis A Meta-Analysis of the Effectiveness of Cell Salvage to Minimize Perioperative Allogeneic Blood Transfusion in Cardiac and Orthopedic Surgery Anesth. Analg., October 1, 1999; 89(4): 861 - 861. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |